Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. was submitted on February 9, 2023, for the month of February 2023. The report serves to incorporate by reference a press release announcing preliminary unaudited financial results for the full year ended December 31, 2022, along with recent operational highlights.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) but are not explicitly detailed in the body of this Form 6-K document.
Material Changes
The filing text does not provide specific data to compare current period performance against prior comparable periods. It only indicates that such results were announced in the accompanying press release.
Guidance, Outlook, and Risks
The filing incorporates the "Forward Looking Statements" section from the referenced press release into the Company's Registration Statements on Form F-3 and Form S-8. No specific guidance, outlook details, or risk factors are enumerated in the text of this Form 6-K itself.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for the actual 2022 year-end financial figures.
- Verify the specific operational highlights mentioned in the press release.
- Examine the "Forward Looking Statements" section in the press release for updated risks and guidance.
- Confirm the status of the Company's Registration Statements (Form F-3 and Form S-8) regarding the incorporation of these new disclosures.